The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Kronos Worldwide Inc

NYSE: KRO
Last

(U.S.) $7.41

Today's change+0.10 +1.37%
Updated August 31 4:05 PM EDT. Delayed by at least 15 minutes.
 

Kronos Worldwide Inc

NYSE: KRO
Last

(U.S.) $7.41

Today's change+0.10 +1.37%
Updated August 31 4:05 PM EDT. Delayed by at least 15 minutes.

Kronos Worldwide Inc up (U.S.)$0.10

Kronos Worldwide Inc closed up Monday by (U.S.)$0.10 or 1.37% to (U.S.)$7.41. Over the last five days, shares have gained 3.35%, but are down 43.09% for the last year to date. Shares have underperformed the S&P 500 by 51.57% during the last year.

Key company metrics

  • Open(U.S.) $7.22
  • Previous close(U.S.) $7.31
  • High(U.S.) $7.47
  • Low(U.S.) $7.15
  • Bid / Ask(U.S.) $7.34 / (U.S.) $8.67
  • YTD % change-43.09%
  • Volume546,605
  • Average volume (10-day)376,825
  • Average volume (1-month)438,480
  • Average volume (3-month)317,142
  • 52-week range(U.S.) $6.91 to (U.S.) $15.92
  • Beta2.72
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward17.83×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $0.60
  • Dividend yield8.10%
  • Trailing EPS(U.S.) -$0.77
Updated August 31 4:05 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-5.92%

Kronos Worldwide Inc has a net profit margin of -5.92%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.04%Sector:Basic MaterialsIndustry:Chemicals - Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue360365374415
Total other revenue--------
Total revenue360365374415
Gross profit47778096
Total cost of revenue314288294319
Total operating expense371333342367
Selling / general / administrative52435748
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)----10
Other operating expenses, total53-83
Operating income-10323248
Interest income (expense), net non-operating-4-5-4-4
Gain (loss) on sale of assets--------
Other--------
Income before tax-15282744
Income after tax-160182032
Income tax, total1459812
Net income-160182032
Total adjustments to net income--------
Net income before extra. items-160182032
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-160182032
Inc. avail. to common incl. extra. items-160182032
Diluted net income-160182032
Dilution adjustment--------
Diluted weighted average shares116116116116
Diluted EPS excluding extraordinary itemsvalue per share-1.380.160.170.28
Dividends per sharevalue per share0.150.150.150.15
Diluted normalized EPSvalue per share-1.380.160.180.28